细胞解离市场 - 全球产业规模、份额、趋势、竞争、机会和预测，按类型、按产品类型、按组织、按最终用户、按地区和竞争进行细分，2020 年至 2030 年

2024年，全球细胞解离市场规模为7.3025亿美元，预计2030年将达到15.4784亿美元，预测期内复合年增长率为13.34%。这一增长主要得益于生物製药领域研究力度的加强、个人化医疗需求的不断增长以及公共和政府对细胞研究的投入不断增加。细胞解离是疫苗研发和细胞扩增等各种应用的关键步骤。组织解离技术的进步、干细胞应用研究的深入发展，以及人们对无酵素解离方法而非酵素解离方法的偏好，预计将在未来几年进一步推动市场扩张。

关键市场驱动因素

对细胞疗法和再生医学的需求不断增长

主要市场挑战

解离后细胞活力与功能完整性

主要市场趋势

自动化和高通量细胞解离技术

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球细胞解离市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（组织解离和细胞分离）
  • 依产品类型（酵素解离产品、非酵素解离产品、仪器及配件）
  • 依组织（上皮组织、结缔组织等）
  • 按最终用户（生物技术公司、製药公司、学术和研究机构等）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：亚太细胞解离市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国 。
  • 印度 。
  • 韩国
  • 日本
  • 澳洲

第七章：欧洲细胞解离市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：北美细胞解离市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第九章：南美细胞分离市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲细胞解离市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 产品开发

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 14 章：全球细胞解离市场：SWOT 分析

第 15 章：竞争格局

• Becton, Dickinson and Company
• Miltenyi Biotec
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Sartorius AG
• Lonza Group Ltd.
• Danaher Corporation
• Merck KGaA
• STEMCELL Technologies
• QIAGEN NV

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Cell Dissociation Market was valued at USD 730.25 million in 2024 and is projected to reach USD 1,547.84 million by 2030, growing at a CAGR of 13.34% during the forecast period. This growth is primarily driven by expanding research efforts in the biopharmaceutical sector, increasing demand for personalized medicine, and rising public and government investments in cell-based research. Cell dissociation is a crucial step in various applications, including vaccine development and cell expansion processes. Advancements in tissue dissociation technologies, increased research in stem cell applications, and the preference for enzyme-free dissociation methods over enzymatic alternatives are expected to further support market expansion in the coming years.

Key Market Drivers

Rising Demand for Cell-Based Therapies and Regenerative Medicine

A major factor fueling the global cell dissociation market is the escalating demand for cell-based therapies and regenerative medicine. Cell dissociation is fundamental in isolating single cells from tissues, an essential step for downstream processes such as immunotherapy, stem cell research, and tissue engineering. Government-backed initiatives, like the U.S. Department of Health and Human Services' "Regenerative Medicine Innovation Project," which allocated over $10 million under the 21st Century Cures Act, are accelerating the adoption of these technologies. The increasing global prevalence of chronic conditions such as Parkinson's disease, cardiovascular disorders, and diabetes has also intensified the need for innovative, cell-based interventions. According to the WHO, chronic illnesses account for more than 70% of global deaths, prompting significant public and private investments in cellular therapies and, by extension, cell dissociation technologies.

Key Market Challenges

Cell Viability and Functional Integrity Post-Dissociation

Maintaining cell viability and functional integrity following dissociation remains a significant challenge in the global market. The enzymatic and mechanical processes used in dissociation can compromise cell membranes, alter surface markers, and disrupt intracellular functions, which are critical for applications like immunophenotyping, single-cell sequencing, and therapeutic use. This issue is particularly concerning in sensitive applications such as stem cell and T-cell therapies. Research funded by institutions like the NIH has shown that prolonged exposure to dissociation enzymes like trypsin can alter phenotypes and reduce the effectiveness of cell-based treatments. Additionally, the lack of standardized protocols for diverse tissue types adds variability to outcomes, impeding reproducibility and regulatory approval in translational research.

Key Market Trends

Automation and High-Throughput Cell Dissociation Technologies

A key trend shaping the cell dissociation market is the increasing adoption of automated and high-throughput technologies in laboratory workflows. Manual dissociation methods are time-intensive and susceptible to variability, particularly in high-volume or GMP-compliant settings. Automated systems streamline the dissociation process, reduce manual errors, and enhance yield and viability, making them increasingly attractive to both research institutions and commercial laboratories. These systems are essential for applications such as flow cytometry, CRISPR gene editing, and single-cell RNA sequencing. Government initiatives supporting the integration of artificial intelligence and smart technologies in biomedical research-such as the NIH's "Bridge2AI" program-are further driving the adoption of automation, ensuring more consistent and reproducible results across cell biology studies.

Key Market Players

• Becton, Dickinson and Company
• Miltenyi Biotec
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Sartorius AG
• Lonza Group Ltd.
• Danaher Corporation
• Merck KGaA
• STEMCELL Technologies
• QIAGEN N.V.

Report Scope:

In this report, the Global Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Dissociation Market, By Type:

• Tissue Dissociation
• Cell Detachment

Cell Dissociation Market, By Product Type:

• Enzymatic Dissociation Products
• Non-Enzymatic Dissociation Products
• Instruments & Accessories

Cell Dissociation Market, By Tissue:

• Epithelial Tissue
• Connective Tissue
• Others

Cell Dissociation Market, By End User:

• Biotechnology Companies
• Pharmaceutical Companies
• Academic and Research Institutes
• Others

Cell Dissociation Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cell Dissociation Market.

Available Customizations:

Global Cell Dissociation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered.
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Dissociation Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Tissue Dissociation & Cell Detachment)
  • 5.2.2. By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories)
  • 5.2.3. By Tissue (Epithelial Tissue, Connective Tissue, and Others)
  • 5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. Asia-Pacific Cell Dissociation Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Product Type
  • 6.2.3. By Tissue
  • 6.2.4. By End user
  • 6.2.5. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Cell Dissociation Market Outlook.
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Tissue
      • 6.3.1.2.4. By End user
  • 6.3.2. India Cell Dissociation Market Outlook.
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Tissue
      • 6.3.2.2.4. By End user
  • 6.3.3. South Korea Cell Dissociation Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Tissue
      • 6.3.3.2.4. By End user
  • 6.3.4. Japan Cell Dissociation Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Product Type
      • 6.3.4.2.3. By Tissue
      • 6.3.4.2.4. By End user
  • 6.3.5. Australia Cell Dissociation Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Product Type
      • 6.3.5.2.3. By Tissue
      • 6.3.5.2.4. By End user

7. Europe Cell Dissociation Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Product Type
  • 7.2.3. By Tissue
  • 7.2.4. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cell Dissociation Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Tissue
      • 7.3.1.2.4. By End user
  • 7.3.2. Germany Cell Dissociation Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Tissue
      • 7.3.2.2.4. By End user
  • 7.3.3. United Kingdom Cell Dissociation Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Tissue
      • 7.3.3.2.4. By End user
  • 7.3.4. Italy Cell Dissociation Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Tissue
      • 7.3.4.2.4. By End user
  • 7.3.5. Spain Cell Dissociation Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Tissue
      • 7.3.5.2.4. By End user

8. North America Cell Dissociation Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Product Type
  • 8.2.3. By Tissue
  • 8.2.4. By End user
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Cell Dissociation Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Tissue
      • 8.3.1.2.4. By End user
  • 8.3.2. Mexico Cell Dissociation Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Tissue
      • 8.3.2.2.4. By End user
  • 8.3.3. Canada Cell Dissociation Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Tissue
      • 8.3.3.2.4. By End user

9. South America Cell Dissociation Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Product Type
  • 9.2.3. By Tissue
  • 9.2.4. By End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Dissociation Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Tissue
      • 9.3.1.2.4. By End user
  • 9.3.2. Argentina Cell Dissociation Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Tissue
      • 9.3.2.2.4. By End user
  • 9.3.3. Colombia Cell Dissociation Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Tissue
      • 9.3.3.2.4. By End user

10. Middle East and Africa Cell Dissociation Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Product Type
  • 10.2.3. By Tissue
  • 10.2.4. By End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Dissociation Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Tissue
      • 10.3.1.2.4. By End user
  • 10.3.2. Saudi Arabia Cell Dissociation Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Tissue
      • 10.3.2.2.4. By End user
  • 10.3.3. UAE Cell Dissociation Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Tissue
      • 10.3.3.2.4. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Global Cell Dissociation Market: SWOT Analysis

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Miltenyi Biotec
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. GE Healthcare
• 15.5. Sartorius AG
• 15.6. Lonza Group Ltd.
• 15.7. Danaher Corporation
• 15.8. Merck KGaA
• 15.9. STEMCELL Technologies
• 15.10. QIAGEN N.V.

16. Strategic Recommendations

17. About Us & Disclaimer